Prostate cancer in patients with pelvic lymph node metastasis: What is the best therapy?

By Hack M.   Zwergel U.   Lehmann J.   Schreier U.   Stockle M.   Zwergel T.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 190-190

Elsevier

Access to resources Recommend Favorite

Prognostic Factor Analysis in Patients with Advanced Prostate Cancer Treated by Castration Plus Anandron or Placebo: A Final Update

By de Reijke T.M.   Derobert E.   The Anandron  

European Urology, Vol. 42, Iss. 2, 2002-08 ,pp. : 139-146

Elsevier

Access to resources Recommend Favorite

Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up

By Oh W.K.   Manola J.   Bittmann L.   Brufsky A.   Kaplan I.D.   Smith M.R.   Kaufman D.S.   Kantoff P.W.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Investigative clinical study on prostate cancer: on the role of the pretreatment total PSA to free testosterone ratio in selecting different biology groups of prostate cancer patients

By Porcaro Antonio   Migliorini Filippo   Romano Mario   Petrozziello Aldo   Antoniolli Stefano   Rubilotta Emanuele   Lacola Vincenzo   Sava Teodoro   Ghimenton Claudio   Caruso Beatrice   Monaco Carmelo   Comunale Luigi  

International Urology and Nephrology, Vol. 42, Iss. 3, 2010-09 ,pp. : 673-681

Springer Publishing Company

Access to resources Recommend Favorite

Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin

By Schlegel P.N.   Kuzma P.   Frick J.   Farkas A.   Gomahr A.   Spitz I.   Chertin B.   Mack D.   Jungwirth A.   King P.   Nash H.   Bardin C.W.   Moo-Young A.  

Urology, Vol. 58, Iss. 4, 2001-10 ,pp. : 578-582

Elsevier

Access to resources Recommend Favorite